Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Galaxy Payroll: Driving Innovation in Human Resources Management
-
Revolutionizing Psychology: Asian Conference on Applied Psychology 2025 Unveils VR Networking and Global Collaboration
-
First Phosphate Reports University Research Reports Relating to the Geological Characterization of its Three Bégin-Lamarche Phosphate Zones
-
Global Competition Launches to Drug 'Undruggable' Cancer Target
-
Cooler Master Launches the CH351: 3D Surround Sound Wireless Gaming Headset for Total Immersion
-
Y-mAbs Provides Strategic Business Update and 2025 Priorities
-
NeoGenomics Announces Chief Executive Officer Succession
-
HBT Financial, Inc. to Announce Fourth Quarter 2024 Financial Results on January 22, 2025
-
Five Star Franchising brands named 2025 Top Franchises by Franchise Business Review
-
U-Haul Opens New and Improved Full-Service Center in Schofield
-
Lumira Ventures Announces Promotion of Suman Rao to Principal
-
Gold Terra Announces Start of 2025 Drilling Program Targeting High-Grade Gold in the Campbell Shear, Con Mine Option Property, NWT
-
Olive Resource Capital Announces December 31, 2024 NAV of C$0.064 per Share
-
G2 Names INE 2025 Networking and Cybersecurity Training Leader
-
Compass Pathways Announces Pricing of Underwritten Offering
-
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC
-
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC
-
Specificity Eyes 2025 for Serious Growth
-
Tilray Brands Reports Q2 2025 Financial Results
-
Belharra Therapeutics Announces Appointment of Sean Buchanan, Ph.D., as Chief Scientific Officer and Retirement of Gary O’Neill, Ph.D.
-
BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)
-
Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, Highlights Upcoming Milestones, and Provides Corporate Update
-
GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents
-
MD Logic Health® Introduces Cool: A Breakthrough In Women's Hormonal Health!
-
Nickel Sulphate Futures Now Live for Trading on Abaxx Exchange
-
New Book Unveils a Neuroscience-Based Framework to Break Free from Divorce Indecision in Just 30 Days
-
Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes
-
Bio-Path Holdings Provides 2025 Clinical and Operational Update
-
Lantronix Names Brent Stringham as CFO
-
Plymouth Industrial REIT Provides Activity Update for Fourth Quarter 2024
-
Aircastle Announces Third Quarter 2024 Results
-
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025
-
Marengo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis
-
Empowering the Next Generation: Aurora Announces German Internship Program
-
Neogen Announces Preliminary¹ Second-Quarter 2025 Results
-
U.S. Energy Corp. Announces Recent AcquisitionTargeting Industrial Gas Production
-
Gencor Announces Receipt of NYSE Regulation Notice Regarding Late Filing of the Annual Report on Form 10-K for the Year Ended September 30, 2024
-
Mediar Therapeutics Enters into Global Licensing Agreement with Lilly to Advance First-in-Class WISP1 Antibody for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
-
AKTIS ONCOLOGY TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
-
Branford Castle Acquires Eastern Dental Management, a Leading Dental Services Organization, from Staple Street Capital
-
Walgreens Boots Alliance Reports Fiscal 2025 First Quarter Results
-
Cipia unveils ADAS capabilities for Cipia-FS10, redefining its fleet safety offering with a 360° Road and Driver Monitoring Solution
-
The Tel-Aviv Stock Exchange Reports Buyback of the Company's shares from Manikay Fund
-
Introducing Pairzon's Next Generation Media Mix Modeling (MMM) Tool
-
CI Financial Announces Filing and Mailing of Circular for Special Meeting to Approve Plan of Arrangement with Mubadala Capital
-
The New York Stem Cell Foundation Research Institute Enters Agreement to Accelerate Precision Drug Discovery for Neurodegenerative Disease
-
Top Food Trends of 2025 That Will Have You Choosing Beef
-
Chemtrade Logistics Income Fund Issues 2025 Guidance and Raises Monthly Distribution
-
The “Hottest” Bagel in New York is Opening Its First Boston Location
